TAEYANG Corporation (KOSDAQ:053620)
South Korea · Delayed Price · Currency is KRW 7,160.00
-20.00 (-0.28%)
At close: Mar 20, 2026
TAEYANG Market Cap
TAEYANG has a market cap or net worth of 57 billion as of March 20, 2026. Its market cap has increased by 11.70% in one year.
Market Cap
57.00B
Enterprise Value
-26.03B
Revenue
140.35B
Ranking
n/a
PE Ratio
4.81
Stock Price
7,160.00
Market Cap Chart
Since March 1, 2002, TAEYANG's market cap has increased from 35.52B to 57.00B, an increase of 60.48%. That is a compound annual growth rate of 1.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 57.00B | 9.98% |
| Dec 30, 2025 | 51.83B | 4.16% |
| Dec 30, 2024 | 49.76B | -17.98% |
| Dec 28, 2023 | 60.66B | -4.15% |
| Dec 29, 2022 | 63.29B | -11.47% |
| Dec 30, 2021 | 71.49B | 6.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoulin Bioscience | 57.37B |
| POINT ENGINEERING | 57.27B |
| Hankukpackage | 57.22B |
| Artist Company | 57.14B |
| Cellromax Science | 57.12B |
| WINPAC | 57.04B |
| 3A Logics | 57.03B |
| DRGEM | 56.98B |